{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:16:47Z","timestamp":1788873407464,"version":"build-2803163510"},"reference-count":29,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T00:00:00Z","timestamp":1683763200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018711","name":"Second Affiliated Hospital of Harbin Medical University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100018711","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Hematology"],"published-print":{"date-parts":[[2023,12,31]]},"DOI":"10.1080\/16078454.2023.2210907","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T11:56:21Z","timestamp":1683806181000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Study on autonomic neuropathy of the digestive system caused by bortezomib in the treatment of multiple myeloma"],"prefix":"10.1080","volume":"28","author":[{"given":"Weiwei","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Hematology, The Second Affiliated Hospital of Harbin Medical University, Harbin, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Second Affiliated Hospital of Harbin Medical University, Harbin, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianjie","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Second Affiliated Hospital of Harbin Medical University, Harbin, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Second Affiliated Hospital of Harbin Medical University, Harbin, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,5,11]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.0003"},{"issue":"1","key":"e_1_3_2_3_1","first-page":"3","article-title":"Epidemiology, staging, and management of multiple myeloma","volume":"9","author":"Padala SA","year":"2021","unstructured":"Padala SA, Barsouk A, Barsouk A, et al. Epidemiology, staging, and management of multiple myeloma. Med Sci (Basel). 2021 Jan;9(1):3.","journal-title":"Med Sci (Basel)"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13147"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22020888"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.2174\/1386207325666220524144147"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-015-0337-6"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70442-5"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30206-6"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2019.05.009"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.191429"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2016-217000"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12790"},{"issue":"6","key":"e_1_3_2_14_1","first-page":"e8400","article-title":"Uncommon presentations of multiple myeloma","volume":"12","author":"Tathineni P","year":"2020","unstructured":"Tathineni P, Cancarevic I, Malik BH. Uncommon presentations of multiple myeloma. Cureus. 2020 Jun;12(6):e8400.","journal-title":"Cureus"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2017.06.009"},{"issue":"11","key":"e_1_3_2_16_1","first-page":"1761","article-title":"Chemotherapy-induced stomatitis and diarrhea","volume":"38","author":"Kadowaki S","year":"2011","unstructured":"Kadowaki S, Yamaguchi K. Chemotherapy-induced stomatitis and diarrhea. Gan To Kagaku Ryoho. 2011;38(11):1761\u20131766.","journal-title":"Gan To Kagaku Ryoho"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-018-0679-9"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-014-2541-6"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e32811ebffe"},{"issue":"8","key":"e_1_3_2_20_1","first-page":"760","article-title":"Early onset of paralytic ileus caused by simultaneous administration of bortezomib and azole antifungals in multiple myeloma patients","volume":"53","author":"Koda Y","year":"2012","unstructured":"Koda Y, Mori T, Shimizu T, et al. Early onset of paralytic ileus caused by simultaneous administration of bortezomib and azole antifungals in multiple myeloma patients. Rinsho Ketsueki. 2012;53(8):760\u2013764.","journal-title":"Rinsho Ketsueki"},{"issue":"5","key":"e_1_3_2_21_1","first-page":"805","article-title":"Once-weekly bortezomib plus dexamethasone therapy induced complete response, reducing severe gastrointestinal adverse events for a patient with relapsed multiple myeloma-a case report","volume":"39","author":"Fukushima T","year":"2012","unstructured":"Fukushima T, Iwao H, Sakai T, et al. Once-weekly bortezomib plus dexamethasone therapy induced complete response, reducing severe gastrointestinal adverse events for a patient with relapsed multiple myeloma-a case report. Gan To Kagaku Ryoho. 2012;39(5):805\u2013807.","journal-title":"Gan To Kagaku Ryoho"},{"issue":"6","key":"e_1_3_2_22_1","first-page":"2297","article-title":"Efficacy and safety of bortezomib plus dexamethasone therapy for refractory or relapsed multiple myeloma: once-weekly administration of bortezomib may reduce the incidence of gastrointestinal adverse events","volume":"31","author":"Fukushima T","year":"2011","unstructured":"Fukushima T, Nakamura T, Iwao H, et al. Efficacy and safety of bortezomib plus dexamethasone therapy for refractory or relapsed multiple myeloma: once-weekly administration of bortezomib may reduce the incidence of gastrointestinal adverse events. Anticancer Res. 2011;31(6):2297\u20132302.","journal-title":"Anticancer Res"},{"issue":"07","key":"e_1_3_2_23_1","first-page":"625","article-title":"Clinical analysis of 26 cases of multiple myeloma with intestinal obstruction treated with bortezomib","volume":"38","author":"Zhang QL","year":"2017","unstructured":"Zhang QL, Liu YZ, Lin DQ, et al. Clinical analysis of 26 cases of multiple myeloma with intestinal obstruction treated with bortezomib. Zhonghua Xue Ye Xue Za Zhi. 2017;38(07):625\u2013627.","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.4103\/sajc.sajc_59_17"},{"key":"e_1_3_2_25_1","first-page":"CD010816","article-title":"Bortezomib for the treatment of multiple myeloma","volume":"4","author":"Scott K","year":"2016","unstructured":"Scott K, Hayden PJ, Will A, et al. Bortezomib for the treatment of multiple myeloma. Cochrane Database Syst Rev. 2016 Apr;4:CD010816.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0000000000000506"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autneu.2020.102718"},{"issue":"2","key":"e_1_3_2_28_1","first-page":"89","article-title":"Diabetic autonomic neuropathy of the gastrointestinal tract","volume":"15","author":"Ku\u017anik E","year":"2020","unstructured":"Ku\u017anik E, Dudkowiak R, Adamiec R, et al. Diabetic autonomic neuropathy of the gastrointestinal tract. Prz Gastroenterol. 2020;15(2):89\u201393.","journal-title":"Prz Gastroenterol"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-1536"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2019.112196"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/16078454.2023.2210907","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T12:08:59Z","timestamp":1702296539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/16078454.2023.2210907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,11]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,12,31]]}},"alternative-id":["10.1080\/16078454.2023.2210907"],"URL":"https:\/\/doi.org\/10.1080\/16078454.2023.2210907","relation":{},"ISSN":["1607-8454"],"issn-type":[{"value":"1607-8454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=yhem20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=yhem20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-01-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2210907"}}